Published in Miner Electrolyte Metab on January 01, 1993
Is calcium replacement therapy unnecessary for severe hypocalcemia associated with rhabdomyolysis? Clin Exp Nephrol (2013) 0.75
Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res (1999) 3.05
Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin. Proc Natl Acad Sci U S A (1984) 1.70
Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis. N Engl J Med (1984) 1.52
Vitamin D and its metabolites in human and bovine milk. J Nutr (1981) 1.40
A role for GATA transcription factors in the androgen regulation of the prostate-specific antigen gene enhancer. Mol Cell Endocrinol (2000) 1.39
Cloning and characterization of a mRNA-encoding rat preprosomatostatin. J Biol Chem (1983) 1.37
Gap-junctional communication is required for the maturation process of osteoblastic cells in culture. Bone (2001) 1.28
Calcitonin mRNA polymorphism: peptide switching associated with alternative RNA splicing events. Proc Natl Acad Sci U S A (1982) 1.22
Characterization of rat calcitonin mRNA. Proc Natl Acad Sci U S A (1980) 1.15
Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis? Lancet (1982) 1.14
Rat pre-prosomatostatin. Structure and processing by microsomal membranes. J Biol Chem (1983) 1.13
Relationship between blood pH and potassium and phosphorus during acute metabolic acidosis. Am J Physiol (1978) 1.13
Suppression of human prostate cancer cell growth by forced expression of connexin genes. Dev Genet (1999) 1.12
Somatostatin elaboration by monolayer cell cultures derived from transplantable rat medullary thyroid carcinoma: synergistic stimulatory effects of glucagon and calcium. Endocrinology (1981) 1.11
Occurrence of vitamin D sulfate in human milk whey. J Nutr (1981) 1.09
Altered expression of the calcitonin gene associated with RNA polymorphism. Nature (1981) 1.08
Immunochemical heterogeneity of calcitonin in plasma. J Clin Endocrinol Metab (1975) 1.07
Structure and expression of a gene encoding human calcitonin and calcitonin gene related peptide. Biochem Biophys Res Commun (1984) 1.06
Combined therapy with thiazide-type and loop diuretic agents for resistant sodium retention. Ann Intern Med (1983) 1.04
Toxic effects of toluene: a new cause of high anion gap metabolic acidosis. JAMA (1979) 1.04
Inhibition of gap-junctional communication induces the trans-differentiation of osteoblasts to an adipocytic phenotype in vitro. J Biol Chem (2001) 1.02
Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment. J Bone Miner Res (1999) 1.01
Evidence for a pro-calcitonin. Biochem Biophys Res Commun (1974) 1.01
Estimation of biologically active intact parathyroid hormone in normal and hyperparathyroid sera by sequential N-terminal immunoextraction and midregion radioimmunoassay. J Clin Endocrinol Metab (1983) 1.01
Prostate cancer progression, metastasis, and gene expression in transgenic mice. Cancer Res (1997) 1.00
Identification of a protein that confers calcitonin gene-related peptide responsiveness to oocytes by using a cystic fibrosis transmembrane conductance regulator assay. Proc Natl Acad Sci U S A (1996) 1.00
Dose response to chlorthalidone in patients with mild hypertension. Efficacy of a lower dose. Clin Pharmacol Ther (1978) 0.99
Severe hypernatremia with impaired thirst. Am J Nephrol (1989) 0.99
Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells. Steroids (1996) 0.98
Incomplete syndrome of renal tubular acidosis induced by lithium carbonate. J Lab Clin Med (1975) 0.98
Gap-junctional communication mediates parathyroid hormone stimulation of mineralization in osteoblastic cultures. Bone (2001) 0.97
Increased plasma and tumor somatostatin-like immunoreactivity in medullary thyroid carcinoma and small cell lung cancer. J Clin Endocrinol Metab (1981) 0.95
Phorbol esters increase calcitonin gene transcription and decrease c-myc mRNA levels in cultured human medullary thyroid carcinoma. J Biol Chem (1985) 0.95
Calcium and skeletal metabolism. West J Med (1975) 0.95
Hormonal regulation of intercellular communication: parathyroid hormone increases connexin 43 gene expression and gap-junctional communication in osteoblastic cells. Mol Endocrinol (1992) 0.93
Detection and characterization of small midregion parathyroid hormone fragment(s) in normal and hyperparathyroid glands and sera by immunoextraction and region-specific radioimmunoassays. J Clin Endocrinol Metab (1981) 0.93
4-Phenyl-3-butenoic acid, an in vivo inhibitor of peptidylglycine hydroxylase (peptide amidating enzyme). Eur J Biochem (1990) 0.93
Identification of the putative cell-free translation product of rat calcitonin mRNA. J Biol Chem (1980) 0.92
2-Methoxyestradiol induces G2/M arrest and apoptosis in prostate cancer. Biochem Biophys Res Commun (2001) 0.92
Effect of hypertonic versus isotonic sodium bicarbonate on plasma potassium concentration in patients with end-stage renal disease. Miner Electrolyte Metab (1991) 0.92
Blunted kaliuresis after an acute potassium load in patients with chronic renal failure. Kidney Int (1983) 0.91
Renal response to sodium restriction in myxedema. Proc Soc Exp Biol Med (1974) 0.91
Squamous carcinoma model of humoral hypercalcemia of malignancy. Endocrinology (1984) 0.91
Serum potassium concentration in acidemic states. Nephron (1981) 0.90
The management of diabetes insipidus in adults. Arch Intern Med (1997) 0.90
Beta-blockers and the kidney. Miner Electrolyte Metab (1982) 0.89
Diabetes mellitus in older persons. Med Clin North Am (1998) 0.89
Secondary hyperparathyroidism in X-linked hypophosphatemic mice. Endocrinology (1982) 0.89
Evaluation of the in vivo and in vitro calcium-regulating actions of noncalcitonin peptides produced via calcitonin gene expression. Endocrinology (1986) 0.89
Hyporeninemia and hypoaldosteronism in diabetes mellitus. Arch Intern Med (1977) 0.89
Impairment of beta 2-adrenoceptor-stimulated potassium uptake in end-stage renal disease. J Clin Pharmacol (1987) 0.88
Human medullary thyroid carcinoma in culture provides a model relating growth dynamics, endocrine cell differentiation, and tumor progression. J Clin Endocrinol Metab (1984) 0.88
Tumor growth and calcitonin during serial transplantation of rat medullary thyroid carcinoma. Endocrinology (1979) 0.88
25,26-Dihydroxycholecalciferol: a precursor in the renal synthesis of 25-hydroxycholecalciferol-26,23-lactone. Biochem Biophys Res Commun (1980) 0.88
Retracted Concurrent measurement of plasma levels of vitamin D3 and five of its metabolites in normal humans, chronic renal failure patients, and anephric subjects. J Lab Clin Med (1981) 0.88
Increased plasma 1,25-dihydroxyvitamin D after low calcium challenge in X-linked hypophosphatemic mice. Endocrinology (1982) 0.86
Radical prostatectomy: geographic and demographic variation. Urology (2000) 0.86
Paired-ion reversed-phase high-performance liquid chromatography of human and rat calcitonin. J Chromatogr (1980) 0.85
Gap-junctional communication in normal and neoplastic prostate epithelial cells and its regulation by cAMP. Mol Carcinog (1996) 0.85
Low anion gap resulting from unexplained exposure to bromide in a patient with renal amyloidosis. J Toxicol Clin Toxicol (1992) 0.85
Beta blockers and renal function: a reappraisal. J Clin Hypertens (1985) 0.85
Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice. Lab Invest (1996) 0.85
Parathyroid hormone up-regulation of connexin 43 gene expression in osteoblasts depends on cell phenotype. J Bone Miner Res (1997) 0.85
Expression of insulin-like growth factor-I and -II genes in rat medullary thyroid carcinoma. FEBS Lett (1987) 0.85
Potassium homeostasis in chronic diabetes mellitus. Arch Intern Med (1977) 0.85
The effect of acute metabolic acidosis on plasma cortisol, renin activity and aldosterone. Horm Res (1979) 0.85
Plasma immunoreactive calcitonin in lung cancer. J Clin Endocrinol Metab (1980) 0.85
Neuroendocrine peptides in the prostate. Urol Res (1995) 0.84
Hypovitaminosis D in the elderly: from bone to brain. J Nutr Health Aging (2008) 0.84
Hyperkalemia from single small oral doses of potassium chloride. Nephron (1984) 0.84
Circulating prosomatostatin-derived peptides. Differential responses to food ingestion. J Clin Invest (1989) 0.84
Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma. Cancer Res (1980) 0.84
Renal acidification in sickle-cell disease. J Lab Clin Med (1976) 0.84
Effect of pyridostigmine bromide on serum bromide concentration and the anion gap. J Am Soc Nephrol (1991) 0.84
Effect of acid-base status on plasma phosphorus response to lactate. Can J Physiol Pharmacol (1984) 0.84
Laxative abuse syndrome. Am J Gastroenterol (1980) 0.83
Medullary thyroid carcinomas secrete a noncalcitonin peptide corresponding to the carboxyl-terminal region of preprocalcitonin. J Clin Endocrinol Metab (1983) 0.83
Gastrin-releasing peptide gene expression in developing, hyperplastic, and neoplastic human thyroid C-cells. Endocrinology (1988) 0.83
Overall and disease-specific survival after radical prostatectomy: geographic uniformity. Urology (2001) 0.83
A non-calcitonin secretory peptide derived from preprocalcitonin. J Biol Chem (1982) 0.83
Biosynthesis of calcitonin gene-related peptide and calcitonin by a human medullary thyroid carcinoma cell line. J Biol Chem (1986) 0.83
Basic calcium phosphate crystals up-regulate metalloproteinases but down-regulate tissue inhibitor of metalloproteinase-1 and -2 in human fibroblasts. Osteoarthritis Cartilage (2001) 0.83
Metabolic alkalosis induced by regional citrate hemodialysis. ASAIO Trans (1989) 0.82
Effect of NH4Cl on plasma aldosterone, cortisol and renin activity in supine man. J Clin Endocrinol Metab (1977) 0.82
Impaired renal concentrating ability in hypothyroid man. Nephron (1976) 0.81
Calcium regulatory action of endogenous rat calcitonin demonstrated by passive immunization with calcitonin antibodies. Endocrinology (1980) 0.81
Renal tubular hyperkalemia. Am J Nephrol (1982) 0.81
Impaired extrarenal disposal of an acute oral potassium load in patients with endstage renal disease on chronic hemodialysis. Miner Electrolyte Metab (1986) 0.81
Assessment of acute and chronic changes in parathyroid hormone secretion by a radioimmunoassay with predominant specificity for the carboxy-terminal region of the molecule. J Clin Endocrinol Metab (1978) 0.81
Dexamethasone stimulates thyrotropin-releasing hormone production in a C cell line. Mol Endocrinol (1989) 0.81
A neuroendocrine peptide derived from the amino-terminal half of rat procalcitonin. Mol Endocrinol (1989) 0.81
Pharmacokinetics of ranitidine in patients with renal failure. J Clin Pharmacol (1986) 0.81
Review of the literature: severe hyperphosphatemia. Am J Med Sci (1995) 0.81
Biosynthesis of an asparagine-linked oligosaccharide-containing calcitonin by a rat medullary thyroid carcinoma cell line. Biochemistry (1986) 0.80
Basal plasma immunoreactive calcitonin in postmenopausal osteoporosis. Metabolism (1980) 0.80